JD
Janet Dillione
Director

Janet Dillione insider trades: CorMedix (CRMD) stock buys and sales

Director, CorMedix Last trade Jan 21, 2026 68 Form 4 filings
$1.5M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2012
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Janet reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 21, 2026CRMD↓ Sell$69K
Dec 9, 2025CRMD↓ Sell$408K
Dec 2, 2025CRMD↓ Sell$467K
Nov 24, 2025CRMD↓ Sell$262K
Nov 14, 2025CRMD↓ Sell$343K
Aug 16, 2019CRMD↑ Buy$50K
May 15, 2019CRMD↑ Buy$75K
Mar 18, 2019CRMD↑ Buy$70K
Dec 12, 2017CRMD↑ Buy$25K
May 15, 2017CRMD↑ Buy$10K
Jun 8, 2016CRMD↑ Buy$10K
Sep 22, 2015CRMD↑ Buy$40K
Aug 9, 2013NUAN↓ Sell$1.2M
Dec 14, 2012NUAN↓ Sell$330K
Feb 14, 2012NUAN↓ Sell$685K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CRMD insiders

Open-market trades in the last 12 months

About Janet Dillione's insider trades

Janet Dillione is a director at CorMedix (CRMD). Since Feb 14, 2012, Janet has reported 7 open-market purchases worth $280K and 8 sales worth $3.8M on SEC Form 4. In the last 12 months: 5 sales ($1.5M).

Their filings also include grants and awards (38 filings), shares withheld for taxes (14 filings), option exercises (5 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.